Pàgina inicial > Resultats de la cerca: Critical Reviews in Oncology/Hematology
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Dipòsit Digital de Documents de la UAB 2 registres trobats  La cerca s'ha fet en 0.01 segons. 
1.
10 p, 1.4 MB SELNET clinical practice guidelines for bone sarcoma / Blay, Jean-Yves (Léon Bérard Center (Lyon)) ; Palmerini, Emanuela (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ; Bollard, Julien (Léon Bérard Center) ; Aguiar Júnior, Samuel (A.C.Camargo Cancer Center) ; Ángel, Martín Osvaldo (Instituto Alexander Fleming (Buenos Aires)) ; Araya, Beatriz (Hospital Dr. R. A. Calderón Guardia (San José)) ; Badilla-González, Ronald (Hospital Dr. R. A. Calderón Guardia (San José)) ; Bernabeu, Daniel (Hospital Universitario La Paz (Madrid)) ; Campos, Fernando (A.C.Camargo Cancer Center (Brasil)) ; CHS, Caro Sánchez (Instituto Nacional de Cancerologia (Tlalpan)) ; Carvajal Montoya, A. (Hospital Dr. R. A. Calderón Guardia (San José)) ; Casavilca-Zambrano, Sandro (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ; Castro-Oliden, Victor (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ; Chacón, Matias (Instituto Alexander Fleming (Buenos Aires)) ; Clara-Altamirano, Miguel Ángel (Instituto Nacional de Cancerologia (Tlalpan)) ; Collini, Paola (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ; Correa Genoroso, Raquel (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ; Costa, Felipe D. (A.C.Camargo Cancer Center (Brasil)) ; Cuellar, M. (Instituto Nacional de Cancerologia (Tlalpan)) ; Dei Tos, Angelo (Treviso General Hospital Treviso (Padua)) ; Domínguez Malagón, Hugo Ricardo (Instituto Nacional de Cancerología (Tlalpan)) ; Donati, Davide Maria (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ; Dufresne, Armelle (Léon Bérard Center (Lyon)) ; Eriksson, Mikael (Skane University Hospital (Lund)) ; Farias-Loza, M. (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ; Frezza, Anna Maria (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ; Frisoni, Tommaso (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ; Garcia-Ortega, Dorian Yarih (Instituto Nacional de Cancerología (Tlalpan)) ; Gelderblom, Hans J (Leiden University Medical Center (Leiden)) ; Gouin, François (Léon Bérard Center (Lyon)) ; Gómez-Mateo, María Carmen (Hospital Universitario Miguel Servet (Saragossa)) ; Gronchi, Alessandro (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ; Haro-Varas, Juan (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ; Hindi, Nadia (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ; Huanca, Lourdes (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ; Jimenez, Natalia (Hospital San Vicente de Paúl (Heredia)) ; Karanian, Marie (Léon Bérard Center (Lyon)) ; Kasper, Bernd (University of Heidelberg (Mannheim)) ; Lopes, Artur (A.C.Camargo Cancer Center (Brasil)) ; Lopes David, B.B. (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ; López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ; Lutter, Guido (Instituto Alexander Fleming (Buenos Aires)) ; Maki, Robert G. (University of Pennsylvania (New York)) ; Martinez-Said, Héctor (Hospital Medica Sur (Mexico)) ; Martinez-Tlahuel, Jorge Luis (Instituto Nacional de Cancerología (Tlalpan)) ; Mello, Celso A. (A.C.Camargo Cancer Center (Brasil)) ; Morales Pérez, José Manuel (Hospital Medica Sur (Mexico)) ; Moura, David S. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Nakagawa, Suely Akiko (A.C.Camargo Cancer Center (Brasil)) ; Nascimento, Antônio Geraldo (A.C.Camargo Cancer Center (Brasil)) ; Ortiz-Cruz, Eduardo J. (Hospital Universitario La Paz (Madrid)) ; Patel, Shreyaskumar (University of Texas MD Anderson Cancer Center (Houston)) ; Pfluger, Yanina (Instituto Alexander Fleming (Buenos Aires)) ; Provenzano, Salvatore (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ; Righi, Alberto (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ; Rodriguez, Andrés (Instituto Alexander Fleming (Buenos Aires)) ; Santos, Telma G. (A.C.Camargo Cancer Center (Brasil)) ; Scotlandi, Katia (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ; MLG, Silva (A.C.Camargo Cancer Center (Brasil)) ; Soulé, Tomás (Instituto Alexander Fleming (Buenos Aires)) ; Stacchiotti, Silvia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ; Valverde, Claudia María (Hospital Universitari Vall d'Hebron) ; Waisberg, Federico Daniel (Instituto Alexander Fleming (Buenos Aires)) ; Zamora Estrada, Esteban (Hospital Dr. R. A. Calderón Guardia (San José)) ; Martín-Broto, Javier (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz)
Bone sarcoma are infrequent diseases, representing < 0. 2% of all adult neoplasms. A multidisciplinary management within reference centers for sarcoma, with discussion of the diagnostic and therapeutic strategies within an expert multidisciplinary tumour board, is essential for these patients, given its heterogeneity and low frequency. [...]
2022 - 10.1016/j.critrevonc.2022.103685
Critical Reviews in Oncology/Hematology, Vol. 174 (june 2022) , p. 103685  
Registre complet - Creative Commons
2.
16 p, 2.1 MB Recent therapeutic advances in urothelial carcinoma : A paradigm shift in disease management / Bellmunt, J. (Department of Medical Oncology. Beth Israel Deaconess Medical Center and IMIM-PSMAR Lab. Harvard Medical School) ; Valderrama, B.P. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Puente, J. (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos) ; Grande, Enrique (MD Anderson Cancer Center Madrid) ; Bolós, M.V. (Pfizer) ; Laínez, Nuria (Hospital Universitario de Navarra) ; Vázquez, S. (Hospital Universitario Lucus Augusti (Lugo)) ; Maroto Rey, Pablo (Institut d'Investigació Biomèdica Sant Pau) ; Climent, Miguel Ángel (Department of Medical Oncology. Valencia Institute of Oncology Foundation) ; Garcia del Muro, Xavier (Institut d'Investigació Biomèdica de Bellvitge) ; Arranz, J.Á. (Hospital General Universitario Gregorio Marañón) ; Durán, Ignacio (Instituto de Investigación Sanitaria Valdecilla (Santander, Cantàbria)) ; Universitat Autònoma de Barcelona
Management of first-line advanced urothelial carcinoma (UC) has consisted during the past three decades in the administration of platinum-based chemotherapy followed by observation. Despite moderate to high response rates to first-line treatment, most patients will relapse shortly after and the outcomes with subsequent therapies are poor with 5-year overall survival rates of 5% in the pre-immunotherapy era. [...]
2022 - 10.1016/j.critrevonc.2022.103683
Critical Reviews in Oncology/Hematology, Vol. 174 (june 2022) , p. 103683  
Registre complet - Creative Commons

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem